Pharmaceutical

Pfizer gets grant for treatment of cancer using engineered immune cells targeting bcma

Discover how Pfizer's patented CARs targeting BCMA offer a groundbreaking method for treating cancer. Learn about the unique ligand-binding and signaling domains for effective treatment.

Apr 25, 2024 - 00:00
Discover how Pfizer's patented CARs targeting BCMA offer a groundbreaking method for treating cancer. Learn about the unique ligand-binding and signaling domains for effective treatment.
Read the original article

Tags:

Previous Article

Johnson & Johnson gets grant for heart ultrasound image selection based on physi...

Next Article

Bicycle Therapeutics gets grant for high affinity binders of nectin-4 for treati...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Flu activity gaining steam in the U.S. as vaccination rates lag

Flu activity gaining steam in the U.S. as vaccination r...

Nov 17, 2023

STAT+: Supreme Court blocks Purdue bankruptcy plan that would shield Sacklers from lawsuits

STAT+: Supreme Court blocks Purdue bankruptcy plan that...

Aug 11, 2023

STAT+: Key House panel plots a new health care package — complicating the chamber’s agenda

STAT+: Key House panel plots a new health care package ...

Jul 18, 2023